MedTrace Logo

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

NCT02151929 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-06-02

No results posted yet for this study

Summary

Evaluation of the feasibility and safety of Bioresorbable Vascular Scaffold (BVS) in patient treated with primary PCI (pPCI).

Conditions

  • ST Elevation Acute Myocardial Infarction

Interventions

DEVICE

Bioresorbable vascular scaffold

stenting of an acute thrombotic lesion in patient within STEMI

DEVICE

Everolimus eluting stent

stenting of an acute thrombotic lesion in patient within STEMI

Sponsors & Collaborators

  • San Giuseppe Moscati Hospital

    lead OTHER

Principal Investigators

  • Emilio Di Lorenzo, MD PhD · Division of Cardiology AO Moscati Avellino ITALY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-08-31
Completion
2014-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02151929 on ClinicalTrials.gov